Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Immunome (IMNM) Forecast
NewsEarningsImmunome (IMNM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Immunome Stock Price, Quotes and Forecasts | NASDAQ:IMNM | Benzinga
Explore Immunome stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IMNM.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immunome (IMNM) stock?
You can purchase shares of Immunome (NASDAQ:IMNM) through any online brokerage.
Who are Immunome (IMNM) competitors?
Other companies in Immunome’s space includes: KalVista Pharma (NASDAQ:KALV), Gyre Therapeutics (NASDAQ:GYRE), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT) and Replimune Group (NASDAQ:REPL).
What is the forecast, or price target, for Immunome (IMNM) stock?
Immunome has a consensus price target of $21.33.
What is the current price for Immunome (IMNM)?
The stock price for Immunome (NASDAQ: IMNM) is $6.735 last updated April 11, 2025 at 1:29 PM EDT.
Does Immunome (IMNM) pay a dividend?
There are no upcoming dividends for Immunome.
When is Immunome (NASDAQ:IMNM) reporting earnings?
Immunome’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Immunome (IMNM) going to split?
There is no upcoming split for Immunome.
What sector and industry does Immunome (IMNM) operate in?
Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.